Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
SBRTvsTACE trial: what clinicians have said so far
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
- NCT03960008 ↗
- Terminated
- Lahey Clinic
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on SBRTvsTACE yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on SBRTvsTACE so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X |
The trial
ClinicalTrials.gov- Official title
- A Randomized Multi-Center Phase III Study of Individualized Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as a Bridge to Transplant in Hepatocellular Carcinoma.
- Phase
- Phase 3
- Status
- Terminated
- Conditions
- Hepatocellular Carcinoma; HCC
- Interventions
- Stereotactic Body Radiation Therapy (SBRT); Trans-Arterial Chemoembolization (TACE); Doxorubin
- Arms
- Stereotactic Body Radiation Therapy (SBRT) · Other
- Trans-Arterial Chemoembolization (TACE) · Other
- Enrollment
- 9
- Primary outcomes
- To Compare the Duration of Disease Control in Treated Lesions When Utilizing SBRT Versus TACE as a Bridging Strategy for Patients With HCC Eligible for Liver Transplantation
- Sponsor
- Lahey Clinic with Varian Medical Systems, Merit Medical Systems, Inc.
- Start
- Mar 1, 2020
- Primary completion
- Feb 28, 2024
- Results posted
- Yes
- Registry record
- NCT03960008 · updated Aug 28, 2024